TrialHealth technology assessment (Winchester, England)2022

Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.

Solomon Tesfaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.